Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients

NCT02116374 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2016-07-12

No results posted yet for this study

Summary

The bacterial diversity of HIV patients digestive microbiota seropositive is poorly understood, it remains to be defined.

Conditions

  • HIV-1 Infection

Interventions

OTHER

Physiopathology study

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Didier Raoult, MD · IHU Méditerranée infection

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02116374 on ClinicalTrials.gov